Zoetis (ZTS) Cash & Current Investments (2012 - 2026)

Zoetis' (ZTS) quarterly Cash & Current Investments came in at $1.9 billion in Q1 2026, up 12.78% year-on-year from $1.7 billion in Q1 2025, and down 20.78% on a QoQ basis from $2.4 billion in Q4 2025.

Zoetis (ZTS) Cash & Current Investments (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Cash & Current Investments data on file, last reported at $1.9 billion in Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 12.78% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 12.78% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 23.3% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $1.9 billion, down from $2.4 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for ZTS reached as high as $3.6 billion in Q4 2022 and fell as low as $1.4 billion in Q2 2025.
  • Historically, Cash & Current Investments has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2024.
  • Across the five-year window, Cash & Current Investments tumbled 43.0% in 2023 and climbed 23.3% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $3.6 billion in 2022, then tumbled by 43.0% to $2.0 billion in 2023, then slipped by 2.65% to $2.0 billion in 2024, then increased by 23.3% to $2.4 billion in 2025, then fell by 20.78% to $1.9 billion in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $1.9 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 428.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 153.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.94 Bn
Dec 31, 2025 2.45 Bn
Sep 30, 2025 2.08 Bn
Jun 30, 2025 1.44 Bn
Mar 31, 2025 1.72 Bn
Dec 31, 2024 1.99 Bn
Sep 30, 2024 1.71 Bn
Jun 30, 2024 1.57 Bn
Mar 31, 2024 1.98 Bn
Dec 31, 2023 2.04 Bn
Sep 30, 2023 1.75 Bn
Jun 30, 2023 1.72 Bn
Mar 31, 2023 2.11 Bn
Dec 31, 2022 3.58 Bn
Sep 30, 2022 2.51 Bn
Jun 30, 2022 2.65 Bn
Mar 31, 2022 3.14 Bn
Dec 31, 2021 3.49 Bn
Sep 30, 2021 3.27 Bn
Jun 30, 2021 3.66 Bn